IGF2BPs also enhanced VEGFA expression in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma, potentially promoting immunosuppressive signaling. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.